6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
13m ago	EXL recognized as 2025 Genesys New Partner of the Year
14m ago	Life Time Sea Otter Classic Showcases How Sport, Community and Industry Come Together
47m ago	Sego Resources Commences 2000 Meter Drill Program in The Southern Gold Area and The Quintana Zone
47m ago	Arya Resources Announces New Gold Discovery: Triplet Zone with Intercept of 6.05 g/t Au over 10.85 M
53m ago	Olive Tree People Inc. Subsidiary Announces 100 Percent Waterless Formulation Patent Filing

About

Dyne Therapeutics Inc (NASDAQ:DYN) — investor relations, events, news, and company updates on 6ix.

Latest News

Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines

Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)

Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)

Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Dyne Therapeutics to Participate in Upcoming Investor Conferences

Financials

Revenue

$0

Market Cap

$3.03 B

EPS

-3.47

Community Chat

Ask AI